Skip to content
SLDBSolid Biosciences Inc.

Earnings

When Solid Biosciences Inc. reports, what it reported each quarter, and how the stock took the results.

39 quarters. Mar 31, 2017 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Mar 5, after the close

Fri, Mar 5, 2027in 107 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 10 – 22

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
—
Revenue, change from a year earlier: Q4 2020 n/m, Q3 2020 n/m, Q2 2020 n/m, Q1 2020 n/m
Net income
-$49.79M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q4 2023—

Latest results

  1. Q3 2026Nov 4, 2026, after the close5.4%by the close of Nov 5
    Revenue
    —
    —
    Net income
    -$53.95M
    N/M
    EPS
    -$0.36
    N/M
  2. Q2 2026Aug 6, 2026, after the close3.5%by the close of Aug 7
    Revenue
    —
    —
    Net income
    -$54.80M
    N/M
    EPS
    -$0.38
    N/M
  3. Q1 2026May 12, 2026, after the close4.4%by the close of May 13
    Revenue
    —
    —
    Net income
    -$56.74M
    N/M
    EPS
    -$0.52
    N/M
  4. Q4 2025Mar 6, 2026, after the closeThe release+18.8%by the close of Mar 9
    Revenue
    —
    —
    Net income
    -$49.79M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026—Nov 4, 202635 d10-Q——-$0.365.4%
Q2 2026Jun 30, 2026—Aug 6, 202637 d10-Q——-$0.383.5%
Q1 2026Mar 31, 2026—May 12, 202642 d10-Q——-$0.524.4%
FY 2025
Q4 2025derivedDec 31, 2025Mar 6, 2026 · after-hoursMar 19, 202678 d10-K———+18.8%
Q3 2025Sep 30, 2025Nov 3, 2025 · after-hoursNov 3, 202534 d10-Q——-$0.4815.3%
Q2 2025Jun 30, 2025—Aug 12, 202543 d10-Q——-$0.42+10.8%
Q1 2025Mar 31, 2025—May 15, 202545 d10-Q——-$0.59+7.0%
FY 2024
Q4 2024derivedDec 31, 2024Feb 18, 2025 · pre-marketMar 6, 202565 d10-K———+31.5%
Q3 2024Sep 30, 2024—Nov 6, 202437 d10-Q——-$0.795.7%
Q2 2024Jun 30, 2024—Aug 13, 202444 d10-Q——-$0.61—
Q1 2024Mar 31, 2024—May 15, 202445 d10-Q——-$0.64—
Earlier years, FY 2017 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 4, 2026447178
10-QAug 6, 2026337935
10-QMay 12, 2026219337
10-KMar 19, 2026115928
10-QNov 3, 2025262818
10-QAug 12, 2025107279
10-QMay 15, 2025072560
10-KMar 6, 2025034644
10-QNov 6, 2024122247
10-QAug 13, 2024096130

Provenance

ProvenanceData status and checks

Solid Biosciences Inc. · CIK 1707502 · Engraved from SEC EDGAR